Literature DB >> 10073267

Mitochondrial disorders: clinical and genetic features.

D K Simon1, D R Johns.   

Abstract

Virtually all cells in humans depend on mitochondrial oxidative phosphorylation to generate energy, accounting for the remarkable diversity of clinical disorders associated with mitochondrial DNA mutations. However, certain tissues are particularly susceptible to mitochondrial dysfunction, resulting in recognizable clinical syndromes. Mitochondrial DNA mutations have been linked to seizures, strokes, optic atrophy, neuropathy, myopathy, cardiomyopathy, sensorineural hearing loss, diabetes mellitus, and other clinical features. Mitochondrial DNA mutations also may play an important role in aging, as well as in common age-related neurodegenerative disorders such as Parkinson's disease. Therefore, it is becoming increasingly important for clinicians to recognize the clinical syndromes suggestive of a mitochondrial disorder, and to understand the unique features of mitochondrial genetics that complicate diagnosis and genetic counseling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073267     DOI: 10.1146/annurev.med.50.1.111

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  29 in total

1.  Mitochondrial myopathy presenting as ataxia with dilated cardiomyopathy.

Authors:  S Gulati; A Das Gupta; M Kabra; R Juneja; M C Sharma; V Kalra
Journal:  Indian J Pediatr       Date:  2001-04       Impact factor: 1.967

Review 2.  Modifier genes for hypertrophic cardiomyopathy.

Authors:  A J Marian
Journal:  Curr Opin Cardiol       Date:  2002-05       Impact factor: 2.161

3.  Mitochondrial biochemical activities and heteroplasmy evolution in established D. subobscura cell line.

Authors:  F Morel; M Renoux; S Alziari
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

4.  Mitochondrial DNA haplogroups and mutations in children with acquired central demyelination.

Authors:  S Venkateswaran; K Zheng; M Sacchetti; D Gagne; D L Arnold; A D Sadovnick; S W Scherer; B Banwell; A Bar-Or; D K Simon
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

Review 5.  Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.

Authors:  Peter J Adhihetty; M Flint Beal
Journal:  Neuromolecular Med       Date:  2008-11-13       Impact factor: 3.843

6.  Mitochondrial Aging Defects Emerge in Directly Reprogrammed Human Neurons due to Their Metabolic Profile.

Authors:  Yongsung Kim; Xinde Zheng; Zoya Ansari; Mark C Bunnell; Joseph R Herdy; Larissa Traxler; Hyungjun Lee; Apua C M Paquola; Chrysanthi Blithikioti; Manching Ku; Johannes C M Schlachetzki; Jürgen Winkler; Frank Edenhofer; Christopher K Glass; Andres A Paucar; Baptiste N Jaeger; Son Pham; Leah Boyer; Benjamin C Campbell; Tony Hunter; Jerome Mertens; Fred H Gage
Journal:  Cell Rep       Date:  2018-05-29       Impact factor: 9.423

7.  Molecular and genomic studies of IMMP2L and mutation screening in autism and Tourette syndrome.

Authors:  Erwin Petek; Thomas Schwarzbraun; Abdul Noor; Megha Patel; Kazuhiko Nakabayashi; Sanaa Choufani; Christian Windpassinger; Mara Stamenkovic; Mary M Robertson; Harald N Aschauer; Hugh M D Gurling; Peter M Kroisel; Klaus Wagner; Stephen W Scherer; John B Vincent
Journal:  Mol Genet Genomics       Date:  2006-10-17       Impact factor: 3.291

Review 8.  In vivo NMR studies of neurodegenerative diseases in transgenic and rodent models.

Authors:  In-Young Choi; Sang-Pil Lee; David N Guilfoyle; Joseph A Helpern
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

9.  Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease.

Authors:  Doris D M Lin; Thomas O Crawford; Peter B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

Review 10.  Genetic determinants of cardiac hypertrophy.

Authors:  Ali J Marian
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.